Comparison of viable and nonviable tumor uptake of Sc-46, Mn-54, Zn-65, In-111 and Au-195 with Ga-67 citrate in a hepatoma model
- PMID: 204486
- DOI: 10.1007/BF00252570
Comparison of viable and nonviable tumor uptake of Sc-46, Mn-54, Zn-65, In-111 and Au-195 with Ga-67 citrate in a hepatoma model
Abstract
The tissue distribution of Sc-46, Mn-54, Zn-65, In-111 and Au-195 were studied in a rat hepatoma model at various time intervals over a 96 h period. The tumor localizing properties of these isotopes were evaluated by examining their incorporation and clearance from viable and nonviable tumor tissue and determining the critical tissue ratios formed with blood and muscle. In general, the results showed greater uptake in viable than nonviable tumor tissue at early time periods (4-24 h). By 96 h, however, the activity remaining in the nonviable tumor tissue exceeded the quantity in viable tumor tissue. This trend was previously noted for Ga-67. When compared with Ga-67, only Mn-54 among the isotopes studied showed remarkably higher viable tumor/blood ratios (4-24 h, 45:1-83:1 respectively). Manganese-54 also showed highly significant accumulation in cardiac muscle with a heart/blood ratio at 4 h superior to comparable values previously reported for Cs-137 and Tl-201. It is suggested that tumor and heart imaging may be feasible utilizing radioactive manganese (Mn-51 or Mn-52) with the new positron imaging systems.
Similar articles
-
Distributions of 137Cs, 201Tl, 203Hg, 203Pb and 57Co in a rat hepatoma model. Comparison with 67Ga.Invest Radiol. 1978 Jan-Feb;13(1):40-5. doi: 10.1097/00004424-197801000-00009. Invest Radiol. 1978. PMID: 204598
-
The effect of certain variables on the tumor and tissue distribution of tracers. II. Carrier effect: rapidity of onset and concentrations necessary for initiation and maximum response.Invest Radiol. 1980 Nov-Dec;15(6):496-501. doi: 10.1097/00004424-198011000-00006. Invest Radiol. 1980. PMID: 7203904
-
The effect of certain variables on the tumor and tissue distribution of tracers. IV. False carriers: ferric citrate.Invest Radiol. 1981 May-Jun;16(3):229-33. doi: 10.1097/00004424-198105000-00014. Invest Radiol. 1981. PMID: 7263158
-
Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer.Theranostics. 2017 Sep 26;7(18):4359-4369. doi: 10.7150/thno.20586. eCollection 2017. Theranostics. 2017. PMID: 29158832 Free PMC article.
-
(68)Ga-radiopharmaceuticals for PET imaging of infection and inflammation.Recent Results Cancer Res. 2013;194:189-219. doi: 10.1007/978-3-642-27994-2_11. Recent Results Cancer Res. 2013. PMID: 22918761 Review.
Cited by
-
The distribution of cadmium-115m chloride, cobalt-57 bleomycin, iodine-125 human serum albumin, selenium-75 selenite and selenomethionine-75 in a rat hepatoma model: a comparison with gallium-67 citrate.Eur J Nucl Med. 1978;3(4):243-8. doi: 10.1007/BF00251400. Eur J Nucl Med. 1978. PMID: 82508 No abstract available.
-
Mechanism of tumor and liver concentration of 111In and 169Yb: 111In and 169Yb binding substances in tumor tissues and liver.Eur J Nucl Med. 1982;7(7):298-303. doi: 10.1007/BF00253424. Eur J Nucl Med. 1982. PMID: 6214397
-
Subcellular distribution of 111In and 169Yb in tumor and liver.Eur J Nucl Med. 1981;6(5):221-6. doi: 10.1007/BF00290567. Eur J Nucl Med. 1981. PMID: 7250139